TS
Congress trade
Rep. Thomas Suozzi (D-NY) sold $50K-$100K of CRSP stock
Thomas Suozzi, U.S. Representative (D-NY), disclosed a sale of CRISPR Therapeutics Ag (CRSP) stock worth $50K-$100K in a STOCK Act filing on Oct 5, 2021.
The trade happened on Sep 20, 2021, 15 days before it was made public.
CRSP has moved -55.9% since the trade date, from $116.47 to $51.42 (Oct 30, 2026 close).
- Traded
- Sep 20, 2021
- Disclosed
- Oct 5, 2021
- Filing delay
- 15 days
- Price since
- -55.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (5)
More CRSP insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.